Medical Acoustics Reports Initial Commercial Shipments of Revolutionary Lung Flute(R).

Perceptronix Medical Inc. to incorporate Lung Flute([R]) into its lung cancer diagnostic platform, LungSign[TM]

BUFFALO, N.Y. -- Medical Acoustics LLC, a commercial-stage medical device company which employs acoustic technologies for diagnostic and therapeutic medical applications, today announced the initial commercial shipments of its innovative and easy to use pulmonary device, the Lung Flute([R]).

Perceptronix Medical Inc., a Vancouver, British Columbia-based cancer diagnostic company, will use the Lung Flute([R])in conjunction with its LungSign[TM] test which assists in the detection of lung cancer. The company's products offer an improvement over existing collection and detection technologies and provide physicians with increased options for prolonging and improving the quality of patients' lives.

Dr. Nicolaas Smit, Vice President of Science & Technology for Medical Acoustics, commented, "Perceptronix has incorporated the Lung Flute([R]) into its risk assessment for lung cancer platform (LungSign[TM]) because of its cost effectiveness, portability and ease of use. This is an important validation of the relevance of our technology in the pulmonary diagnostic marketplace. We believe there are a vast number of diagnostic applications for the Lung Flute([R]) and are aggressively pursuing those prospects."

"The Lung Flute([R]) is a user-friendly method for patients to provide quality sputum for early detection testing on our platforms when trying to identify those at risk for lung cancer," said Rohini Hira, VP of Sales and Marketing, of Perceptronix Medical. "This, combined with its small size and ease of use, has enabled us to broaden the market for our LungSign[TM] product. Early detection testing can now be implemented in any doctor's office throughout the world. The LungSign[TM] kits may now be ordered via the internet at www.LungSign.com."

The Lung Flute([R]) is a small, flute-shaped plastic device that can assist in the harvesting of sputum for diagnostic purposes. It generates a specific low frequency sound when the user blows into it and the resulting sound waves vibrate the airways and lung secretions, causing the deep lung secretions to thin and be expelled. The Lung Flute([R]) enables pharmaceutical developers to monitor inflammatory biomarkers during an asthma attack or at various stages of obstructive or restrictive pulmonary events.

About Medical Acoustics LLC

Medical Acoustics, LLC is a privately held, commercial-stage medical device company located in Buffalo, New York. It is built on ten years of research and development in the science of applied acoustics. The Company's first product, the patented and FDA-cleared Lung Flute([R]), is a revolutionary medical device which should play a significant role in the clinical diagnosis of asthma, chronic bronchitis, community acquired pneumonia, lung cancer and tuberculosis.

Medical Acoustics' mission is to design and develop devices employing acoustic technologies for diagnostic and therapeutic medical applications. More information on the Company and the Lung Flute([R]) can be found at www.medicalacoustics.com.

About Perceptronix Medical Inc.

Perceptronix Medical Inc. (founded in 1999) is a private cancer diagnostics company based in Vancouver, Canada. Perceptronix commercializes early cancer detection technologies developed in partnership with the BC Cancer Agency, a world-leader in cancer care and research, with a particularly notable track record in pioneering early cancer detection programs.

Perceptronix is focused on offering quantitative image cell analysis services for early cancer detection. Perceptronix' products and services offer an improvement over existing detection and localization technologies and provide physicians with increased options for prolonging and improving the quality of patients' lives.